Page 2,217«..1020..2,2162,2172,2182,219..2,2302,240..»

National MS Society Invests $28 Million in New Research to Stop Multiple Sclerosis, Restore Function and End MS Forever

Posted: Published on April 8th, 2015

NEW YORK, April 8, 2015 /PRNewswire-USNewswire/ -- The National Multiple Sclerosis Society has committed $28 million to support an expected 84 new MS research projects and training awards. These are part of a comprehensive research strategy aimed at stopping MS, restoring function that has been lost, and ending the disease forever for every single person with MS. This financial commitment is the latest in the Society's relentless research efforts to move us closer to a world free of MS, and part of a projected investment of over $52 million in 2015 alone to support 380 new and ongoing studies around the world. So that no opportunity is wasted, the Society pursues all promising paths, while focusing on priority areas including progressive MS, nervous system repair, gene/environmental risk factors and wellness and lifestyle. Just a few of the new cutting-edge research projects include a University of California, San Francisco-led consortium focusing on a comprehensive analysis of the gut microbiome to develop probiotic strategies for stopping progressive MS; a pilot trial at Johns Hopkins University exploring the tolerability of a diet that intermittently restricts calorie intake as a treatment for disease activity in people with MS; pre-clinical studies by a commercial firm … Continue reading

Posted in MS Treatment | Comments Off on National MS Society Invests $28 Million in New Research to Stop Multiple Sclerosis, Restore Function and End MS Forever

It Takes Two To Tango: Combine Diagnostics And Drugs For Precision Medicine

Posted: Published on April 8th, 2015

Personalization is the New Name of the Game Precision medicine, also known as personalized medicine, is a concept of combining a drug with a test that is modified to a persons genetic disposition. The test has the ability to predict disease risk, diagnose disease and monitor therapeutic response. Given the huge problem of drug failure rates, the concept of companion diagnostics in the realm of precision medicine has gained huge momentum since 2010. Precision medicine involves the selection of diagnostic tests (companion diagnostics) that have the potential to identify changes in each patients cells. The use of that knowledge may help prevent and treat diseases through the development of treatment strategies to target these specific molecular alterations. Ultimately, the goal of precision medicine is to improve patient outcomes. Figure 1 shows the failure rates for drugs in several disease categories today. Personalized medicine can help save billions of dollars for the healthcare economy globally. How Big is the Opportunity? By 2020, the companion diagnostics market will experience a growth of 20.4 percent globally. In 2014, the market for test sales and test services alone was $2.4 billion and is expected to reach $6.9 billion globally. Figure 2 shows the percentage … Continue reading

Comments Off on It Takes Two To Tango: Combine Diagnostics And Drugs For Precision Medicine

Daily Digest: The horse stem cell fix is in for Colorado, and 9 other stories

Posted: Published on April 8th, 2015

Brenda Simmons hugs her horse Little Brother at her ranch in Granby late last month. Simmons and Little Brother have had stem cell therapy on their legs, preventing debilitating issues for both. (Andy Cross, The Denver Post) Colorado Parks and Wildlife officers removed about 100 prairie dogs. (Courtesy Malia Reeves) Your daily resource for late-breaking news, upcoming events, the Denver weather forecast, Denver traffic information, and the stories that will be talked about on Wednesday, April 8, 2015. Download our iPhone, iPad and Android apps for breaking news throughout the day. 1. THE HORSE FIX IS IN The story of how researchers are using some horse sense to innovate stem cell joint therapies. Close to home, horses are leading humans into new territory, inspiring not only patients but researchers in regenerative therapies at Colorado State University in Fort Collins and the University of Colorado Hospital in Denver. 2. NOBLE TO CUT 100 ENERGY JOBS Noble Energy, Colorado's second largest oil producer, said Tuesday that in the face of low prices it is reorganizing its operations cutting 100 jobs in Denver and Greeley. 3. 100 SEIZED PRAIRIE DOGS IN RODENT LIMBO State wildlife agents and police officers seized about 100 prairie … Continue reading

Comments Off on Daily Digest: The horse stem cell fix is in for Colorado, and 9 other stories

Okyanos Cell Therapy: From Burnout to Fearless

Posted: Published on April 8th, 2015

Freeport, Grand Bahama (PRWEB) April 08, 2015 Amy was searching for a way to get her type 1 diabetes under control when she was referred to Okyanos, the leader in cell therapy. After years of regular visits to the hospital for diabetes, neuropathy and fibromyalgia, she was looking for something that would help her lead a healthier, more normal life. No stranger to pain, Amy has had more than her share of treatments, including meditation, biofeedback, physical therapy and medications, getting her to a point of functional with very bad flare ups. Amy experienced a condition called diabetes burnout which can occur when one gets tired of the endless attention diabetes care requires. After such a period, just 19 and a sophomore in college, Amy woke up one day with swollen feet and persistent horrible pain. She went home to Florida for spring break and ended up in the hospital for six weeks with a neuropathy diagnosis. Neuropathy is common in older diabetics but at a young age, the diagnosis threatened what shred of normal she had left. I couldnt sleep with a blanket and it was hard to have anything on my feet. I had to shake the bed … Continue reading

Comments Off on Okyanos Cell Therapy: From Burnout to Fearless

Nanomedicine Aims New Treatments at Cancer and Dangerous Wounds

Posted: Published on April 8th, 2015

Working on a very small scale lets scientists give drugs abilities denied to larger molecules Harry Campbell A molecule of DNA, holding its blueprint for life, is about 2.5 billionths of a meter in diameter. Scientists now have the ability to push and pull and build molecules of that size, as well as to create devices that sense them with unprecedented precision. These skills, gained through painstaking work during the past decade, are leading to new medicines and ways of diagnosing disease. In this special report, Scientific American examines what nanomedicine is bringing us now, what is coming soon and what the future will likely hold. Right now chemotherapy is a major focus, and drugs that can slip into tumors because of their fine-grained construction are showing success where other medications fail patients [see Cancer Drugs Hit Their Mark, on page 44]. Diagnostic tests are also taking advantage of the small sizes, using probes of unusually shaped DNA that can detect cancer with remarkable accuracy. Next, in the near future, patients should be able to use smart bandages made with nano-sized molecules that enhance the healing of severe woundsor that signal doctors when healing is not happening [see A Smarter … Continue reading

Comments Off on Nanomedicine Aims New Treatments at Cancer and Dangerous Wounds

Global In-vitro Fertilization (IVF) Devices Market 2015-2019 with Cook Medical, Cooper Surgical, Irvine Scientific …

Posted: Published on April 8th, 2015

DUBLIN, Apr. 08, 2015 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/qh77cr/global_invitro) has announced the addition of the "Global In-vitro Fertilization (IVF) Devices Market 2015-2019" report to their offering. The Global IVF Devices market to grow at a CAGR of 10.8% over the period 2014-2019 Globally one in six couples face infertility issues. IVF is one of the popular treatments that has benefitted childless couples, single mothers, and LGBT community. It involves specific and complicated procedures with mixed proportion of both success and failure. According to CDC, nearly 1.5 million cycles of IVF is performed worldwide every year, and about 55 percent of the reported cycles are carried out in Europe. The Global IVF Devices market is growing at high pace, promising high return on investment. One key trend upcoming in this market is the increase in medical tourism. Many couples from developed countries travel to developing countries such as India and Thailand for cheaper IVF treatments. According to the report, increased adoption of IVF treatment and its enhanced success rates are the major contributors to the growth of the market. While other ART procedures offer success rates of about 33 percent for patients below 35 years, the average rate of success for … Continue reading

Posted in IVF Treatment | Comments Off on Global In-vitro Fertilization (IVF) Devices Market 2015-2019 with Cook Medical, Cooper Surgical, Irvine Scientific …

Let’s Play The Sims 3 – Perfect Genetics Challenge – Episode 67 – Video

Posted: Published on April 8th, 2015

Let's Play The Sims 3 - Perfect Genetics Challenge - Episode 67 Thank you all for giving me so many baby names but sadly when I recorded this video and other I did not have your names. But don't worry we will have many kids and I will try my best to use... By: vampiregirl101101101 … Continue reading

Posted in Genetics | Comments Off on Let’s Play The Sims 3 – Perfect Genetics Challenge – Episode 67 – Video

Cannaventure genetics – Video

Posted: Published on April 8th, 2015

Cannaventure genetics Sfv og x Ortega got 2 to pop so now its on. By: (RMC)rockymountaincultivators … Continue reading

Posted in Genetics | Comments Off on Cannaventure genetics – Video

Hidden burden: Most people carry recessive disease mutations

Posted: Published on April 8th, 2015

New approach estimates the average number of mutations per person that cause disease when inherited from both parents Humans carry an average of one to two mutations per person that can cause severe genetic disorders or prenatal death when two copies of the same mutation are inherited, according to estimates published today in the journal Genetics. The new numbers were made possible by a long-term collaboration between medical researchers and a unique community that has maintained detailed family histories for many generations. "These records offered a fantastic opportunity to estimate disease mutation carrier rates in a new way that disentangles the effects of genetic and socioeconomic factors," said lead author Ziyue Gao of the University of Chicago. Most genetic disorders that result in sterility or childhood death are caused by recessive mutations, DNA sequence variants that are harmless when a person carries only one copy. But if such mutations are present at both copies (where one copy was inherited from each parent), they can cause devastating diseases like cystic fibrosis. Recessive disease mutations are much more common than those that are harmful even in a single copy, because such "dominant" mutations are more easily eliminated by natural selection. But exactly … Continue reading

Posted in Genetics | Comments Off on Hidden burden: Most people carry recessive disease mutations

Bristol-Myers Signs An Exclusive Pact In Gene Therapy For Treating Cardiovascular Disorders

Posted: Published on April 8th, 2015

Perpetuating the surge of interest in gene therapy technology from major pharmaceutical companies, such as Pfizer Inc. (PFE) and Novartis Inc. (NVS), biopharmaceutical company Bristol-Myers Squibb Co. (BMY) announced a partnership agreement with gene therapy research and development company uniQure NV (QURE) which gives them exclusive rights over uniQures gene therapy technology development for up to 10 genetic targets, for treating cardiovascular diseases, among others. Marking the first foray of Bristol-Myers into gene therapy, the deal gives the company the sole right to develop uniQures gene therapy drugs to treat diseases such as heart failure, which is one of the most common health problems in the world today. Cardiovascular disease is expected to affect about 40 million people around the world by 2030. Bristol-Myers Squibb has an excellent and long-standing track record of success in discovering and developing treatments for cardiovascular diseases and in embracing advancing technologies for the treatment of human diseases, Carl Decicco, Ph.D., head of Discovery, R&D, Bristol-Myers Squibb said in a statement issued by the company. Collaborating with uniQure, a clear leader in the field with an innovative and validated gene therapy platform, further strengthens our capability to bring forward transformational new therapeutics for difficult-to-treat diseases. … Continue reading

Posted in Gene Therapy | Comments Off on Bristol-Myers Signs An Exclusive Pact In Gene Therapy For Treating Cardiovascular Disorders

Page 2,217«..1020..2,2162,2172,2182,219..2,2302,240..»